BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32305128)

  • 21. Mesenchymal stem cell therapy targeting mitochondrial dysfunction in acute kidney injury.
    Zhao L; Hu C; Zhang P; Jiang H; Chen J
    J Transl Med; 2019 May; 17(1):142. PubMed ID: 31046805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular vesicles derived from mesenchymal stem cells as a potential therapeutic agent in acute kidney injury (AKI) in felines: review and perspectives.
    Kraińska MM; Pietrzkowska N; Turlej E; Zongjin L; Marycz K
    Stem Cell Res Ther; 2021 Sep; 12(1):504. PubMed ID: 34526105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oct-4 Enhanced the Therapeutic Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Acute Kidney Injury.
    Zhang ZY; Hou YP; Zou XY; Xing XY; Ju GQ; Zhong L; Sun J
    Kidney Blood Press Res; 2020; 45(1):95-108. PubMed ID: 31927554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress toward the Clinical Application of Mesenchymal Stromal Cells and Other Disease-Modulating Regenerative Therapies: Examples from the Field of Nephrology.
    Hickson LJ; Herrmann SM; McNicholas BA; Griffin MD
    Kidney360; 2021 Mar; 2(3):542-557. PubMed ID: 34316720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells.
    Du T; Zhu YJ
    Mediators Inflamm; 2014; 2014():261697. PubMed ID: 24839354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury.
    Zhao L; Hu C; Zhang P; Jiang H; Chen J
    Stem Cell Res Ther; 2018 Aug; 9(1):225. PubMed ID: 30139368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T.
    Zhang R; Li J; Xin L; Xie J
    Ren Fail; 2015; 37(8):1363-9. PubMed ID: 26248484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model.
    Moghadasali R; Azarnia M; Hajinasrollah M; Arghani H; Nassiri SM; Molazem M; Vosough A; Mohitmafi S; Najarasl M; Ajdari Z; Yazdi RS; Bagheri M; Ghanaati H; Rafiei B; Gheisari Y; Baharvand H; Aghdami N
    Cytotherapy; 2014 Jun; 16(6):734-49. PubMed ID: 24801377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury.
    Tögel F; Cohen A; Zhang P; Yang Y; Hu Z; Westenfelder C
    Stem Cells Dev; 2009 Apr; 18(3):475-85. PubMed ID: 18564903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges.
    Chen F; Chen N; Xia C; Wang H; Shao L; Zhou C; Wang J
    Cell Transplant; 2023; 32():9636897231164251. PubMed ID: 37013255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal Stromal Cell Uses for Acute Kidney Injury-Current Available Data and Future Perspectives: A Mini-Review.
    Zilberman-Itskovich S; Efrati S
    Front Immunol; 2020; 11():1369. PubMed ID: 32793191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy: A new treatment strategy for MSC-based therapy in acute kidney injury (Review).
    Jia H; Yan Y; Liang Z; Tandra N; Zhang B; Wang J; Xu W; Qian H
    Mol Med Rep; 2018 Mar; 17(3):3439-3447. PubMed ID: 29257336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury.
    Brunswig-Spickenheier B; Boche J; Westenfelder C; Peimann F; Gruber AD; Jaquet K; Krause K; Zustin J; Zander AR; Lange C
    Stem Cells Dev; 2010 May; 19(5):719-29. PubMed ID: 20143956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.
    Perico N; Casiraghi F; Remuzzi G
    J Am Soc Nephrol; 2018 Feb; 29(2):362-375. PubMed ID: 29191959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease.
    Yun CW; Lee SH
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30939749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.
    Xu H; Chen C; Hu L; Hou J
    Curr Gene Ther; 2017; 17(6):453-460. PubMed ID: 29446737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
    Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
    Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regenerative pharmacology for the treatment of acute kidney injury: Skeletal muscle stem/progenitor cells for renal regeneration?
    Pavyde E; Usas A; Maciulaitis R
    Pharmacol Res; 2016 Nov; 113(Pt B):802-807. PubMed ID: 27001227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulsed focused ultrasound enhances the therapeutic effect of mesenchymal stromal cell-derived extracellular vesicles in acute kidney injury.
    Ullah M; Liu DD; Rai S; Razavi M; Concepcion W; Thakor AS
    Stem Cell Res Ther; 2020 Sep; 11(1):398. PubMed ID: 32928310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regenerative abilities of mesenchymal stem cells via acting as an ideal vehicle for subcellular component delivery in acute kidney injury.
    Zhao L; Hu C; Han F; Wang J; Chen J
    J Cell Mol Med; 2020 May; 24(9):4882-4891. PubMed ID: 32281261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.